Home » Topics » Regulatory

Regulatory
RSS

Malignant melanoma indication approved for Intron A in U.K.

Aug. 27, 1997

Actiq scheduled for FDA advisory committee review

Aug. 26, 1997

Living human tissue approved for marketing in Canada

Aug. 22, 1997

Supplemental NDA approved for Cipro

Aug. 22, 1997

Infanrix Hep B approved in all EU countries

Aug. 19, 1997

Twinrix now available for pediatric use

Aug. 18, 1997

New spironolactone formulation imparts improved bioavailability, clinical response

Aug. 13, 1997

Imminent launch of Novartis' Alzheimer's disease therapy

Aug. 12, 1997

First approval for Elan's Diastat

Aug. 8, 1997

Paclitaxel approved by FDA for AIDS-related KS

Aug. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026